EP3193929
TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.9.2015EP published:
12.6.2019EP application number:
15763016.1
EPO information:
European Patent Register
Max expiry date:
14.9.2035
Title:
TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES
Timeline
Today
15.9.2015EP application
12.6.2019EP Publication
Owner
Name:
Innate PharmaAddress:
117, Avenue de Luminy, 13009, Marseille, FR
Inventor
Name:
ANDRE, PascaleAddress:
Marseille, FR
Name:
BLERY, MathieuAddress:
Marseille, FR
Name:
PATUREL, CarineAddress:
Marcy l'Etoile, FR
Name:
SOULAS, CarolineAddress:
Marseille, FR
Name:
WAGTMANN, NicolaÏAddress:
Cassis, FR
Priority
Number:
201462050948 PDate:
16.9.2014Country:
US
Number:
201462067642 PDate:
23.10.2014Country:
US
Number:
201462083929 PDate:
25.11.2014Country:
US
Number:
201462093141 PDate:
17.12.2014Country:
US
Number:
201462093124 PDate:
17.12.2014Country:
US
Classification
Categories:
A61K 39/395, C07K 16/28, A61P 35/00, A61P 29/00, A61K 39/00, C07K 16/30